openPR Logo
Press release

Biosimilars Market Is Gaining Huge Growth In Upcoming Years

02-22-2024 02:35 PM CET | Health & Medicine

Press release from: The Insight Partners

Biosimilars Market

Biosimilars Market

According to our new research study on "Biosimilars Market Forecast To 2028 - Global Analysis by Disease Indication, Drug Class, Route of Administration, End User," the biosimilars market size is expected to reach US$ 18,435.89 million in 2021 to US$ 1,36,069.53 million by 2028; it is estimated to register a CAGR of 34.8% during the forecast period.

Get Exclusive Sample Copy of This Report @

The report highlights trends prevailing in the market, and the factors driving and hindering the biosimilars market growth. The growth of the global biosimilars market is attributed to the increasing prevalence of chronic diseases, the cost-effectiveness of biosimilar drugs, and the rising approvals of biosimilars. Additionally, the collaborations among manufacturers for biosimilars and clinical trials are likely to emerge as significant future trends in the market during the forecast period. However, high-cost involvement and complexities in biosimilar product manufacturing are among the market deterrent factors.

Biosimilars Market: Competitive Landscape and Key Developments: Amgen Inc, Celltrion Inc, Sanofi SA, Biocon Ltd, Pfizer Inc, Samsung Bioepis Co Ltd, Coherus BioSciences Inc, Eli Lilly and Co, Sandoz AG, Teva Pharmaceutical Industries Ltd, and Dr. Reddy's Laboratories Ltd are among the leading companies operating in the global biosimilars market.

Contact Us:
If you have any queries about this report or if you would like further information, please contact us:
Contact Person: Ankit Mathur
Phone: +1-646-491-9876

About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Biosimilars Market Is Gaining Huge Growth In Upcoming Years here

News-ID: 3395677 • Views:

More Releases from The Insight Partners

Consumer Genomics: A Guide to Understanding the Process
Consumer Genomics: A Guide to Understanding the Process
Consumer genomics market is growing as it is very frictionless. A patient can purchase a genetic test online and then receive a test kit by mail and collect a DNA sample in their own home. Patients will receive the results at home and don't need any guidance of a genetic counselor or medical practitioner. Get More Details with Sample PDF Copy @ Consumer Genomics Market: Competitive Landscape and Key Developments: •
Cell Therapy Instruments: A Guide to Understanding the Process
Cell Therapy Instruments: A Guide to Understanding the Process
Cell therapy is a procedure where living and intact cells are injected, implanted, or grafted into the patient's body. For instance, a person who has cancer is injected with T cells during his/her course of immunotherapy. The cell therapy instruments ranges from injections to surgical implantation using special devices. Get More Details with Sample PDF Copy @ Cell Therapy Instruments Market: Competitive Landscape and Key Developments: • Thermo Fisher Scientific Inc. • MERCK KGaA • Lonza • Cytiva (GE
Bacteria Detection Kits Market Partnering Deals of Key Players - 2031
Bacteria Detection Kits Market Partnering Deals of Key Players - 2031
Global Bacteria Detection Kits Market Research Report initially provides a basic overview of the industry that covers definition, applications and manufacturing technology, post which the report explores into the international players in the market. Download Sample PDF @ Key Players Analysis: Minerva Biolabs GmbH PromoCell GmbH Creative Diagnostics Sartorius AG Charm Sciences Abnova Corporation BioVisible Genetic Signatures ECHA MICROBIOLOGY LTD NEMIS Technologies AG The report covers key developments in the Bacteria Detection Kits Market as organic and inorganic growth strategies. Various companies
Dairy Enzymes Market Key Product Segments, Application Analysis and Industry Gro …
The Insight Partners has added Latest Report on Dairy Enzymes Market. Research Report mainly includes Size, Share, growth Factors, sales, Demand, Revenue, Trade, Forecast and Global companies Analysis. To offer more clarity regarding the industry, the report takes a closer look at the current status of various factors including but not limited to supply chain management, niche markets, distribution channel, trade, supply, and demand and production capability across different countries. Download

All 5 Releases

More Releases for Biosimilars

Global Biosimilars Market 2021-2028 | Price Advantage of Biosimilars Over Biolog …
The global Biosimilars market focuses on encompassing major statistical evidence for the Biosimilars industry as it offers our readers a value addition on guiding them in encountering the obstacles surrounding the market. A comprehensive addition of several factors such as global distribution, manufacturers, market size, and market factors that affect the global contributions are reported in the study. In addition, the Biosimilars study also shifts its attention with an in-depth
Growth of the Biosimilars Market Is Mainly Driven by Increasing Number of Approv …
A biosimilar is a biologic medical product that is similar to another already approved biological medicine, in terms of quality, safety, and efficacy. Biosimilars are a class of therapeutic drugs that provide additional treatment options and help reduce healthcare costs. Thus, there is an increasing demand for biosimilar drugs due to increasing prevalence of autoimmune diseases, key factor driving the growth of the biosimilars market. According to the National Stem
Global Oncology Biosimilars Market | Global Oncology Biosimilars Industry | Onco …
The oncology biosimilars market involves of sales of medicine and drug interrelated products for cancer treatment. Biosimilars are pharmaceuticals which are produced using cell lines and are fashionable to the manufacturer. The manufacturing of such cell line processes is a multipart and time-consuming procedure. According to the report analysis, ‘Oncology Biosimilars Market Global Report 2020-30’ states that the worldwide oncology biosimilars market was worth USD 2990.34 million in 2019. It is
Global Biosimilars Market | Global Biosimilars Industry | Global Biosimilars Mar …
The biosimilars market involves of sales of biosimilars and associated services that are cast-off to treat chronic sicknesses such as diabetes, arthritis, and cancer. The Biosimilars are pharmaceuticals that are produced using cell lines and offers no clinical difference as linked to biologics. The Biosimilars are made once the patent of biologics is deceased. According to the report analysis, ‘Biosimilars Market Global Report 2020-30’ states that the worldwide biosimilars market was
Global Oral Biologics and Biosimilars Market | Global Oral Biologics and Biosimi …
The oral biologics and biosimilar market contain of sales of oral biologics and biosimilar products and associated services utilized to treat chronic syndromes such as diabetes, arthritis, cancer. Biologics are drugs completed from living cells using exceedingly complex technology while biosimilars are generated to function similarly to biologics but are not matching to biologics. Biosimilars offer energetic properties as any licensed biologic drug. The oral biologics and biosimilar market encompass
Insulin Biosimilars Market, by Biosimilar Type Rapid-acting Biosimilars, Long-ac …
Diabetes is a group of metabolic disease characterized by high blood sugar level due to inadequate secretion of insulin. Common symptoms of diabetes include increased hunger, tiredness, weight loss, and excessive thirst and urination. The prevalence of diabetes is increasing, in turn, boosting demand for insulin biosimilar. For instance, according the World Health Organization (WHO) report in 2014, globally around 422 million adults were living with diabetes and 1.5 million